Document Type : Case Report

Authors

1 Department of Pediatric’s, University Teaching Hospital, Belfort, Algier’s, Algeria.

2 Departement of Pediatric’s, University Teaching Hospital, Belfort, Algier’s, Algeria.

3 Departement of Hemobiology University Teaching Hospital Mustapha Bacha, Algier’s, Algeria.

4 Center for the Study of Immune Deficits Tour, University Teaching Hospital Necker, Paris, France.

5 Center of Normal and Pathological Homeostasis of the Immune System Laboratory, University Teaching Hospital Necker, Paris, France.

6 Unit of Pediatric Immunology, Hematology and Rheumatology (UIHR); University Teaching Hospital Necker, Paris, France.

7 Pediatric Hemato-Oncology Department, University Teaching Hospital Trousseau Paris, France.

Abstract

Familial haemophagocytic lymphohistiocytosis (FHL) is a rare autosomal recessive disorder of immune dysregulation associated with uncontrolled T cell and macrophage activation and hypercytokinaemia. HLH affects primarily pediatric population, mainly infants of less than 3 months of age. It is important to have a high index of suspicion for diagnosis since an early diagnosis is crucial to decrease the significant mortality associated the disease. This article gives a case historie and review the varied clinical presentations, pathophysiology, prognosis and treatment of the entity.

Graphical Abstract

Hemophagocytic Lymphohistiocytosis and Diagnostic Difficulties

Keywords

Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991; 18(1): 29-33. [PMID]

Rohr J, Beutel K, Maul-Pavicic A. Atypical familial hemophagocytic lymphohistiocytosis due to mutation in UNCC13D and STXBP2 overlaps with primary immunodeficiency disease. Hematologica. 2010; 95(12): 2080–7.[crossref]

Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohystiocytosis. Hematology Am Soc Hematol Educ Program. 2005; 82–8. [crossref]

C Gholam, S Grigoriadou, KC Gilmour, HB Gaspar. Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management. Clinical and Experimental Immunology. British Society for Immunology. 2011; 163(3): 271–283. [crossref]

Henter JI. Biology and treatment of familial hemophagocyticlymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and trigerring of apopitosis. Med Pediatr Oncol. 2002; 38: 305-309. [crossref]

Castillo L, Carcillo J.  Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009; 10(3): 387-92. [crossref]

Gauvin F, Toledano B, Champagne J, Lacroix J.  Reactive hemophagocytic syndrome presenting as a component of multiple organ dysfunction syndrome. Crit Care Med. 2000; 28(9): 3341-3345. [crossref]

Karapsinar B, Yilmaz D, Balkan C, Akin M. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis. Pediatr Crit Care. 2009; 10(3): 285-290. [crossref]

Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2013; 2013: 605-611. [crossref]

Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999; 286(5446): 1957-1959. [crossref]

Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008; 50(6): 1227–1235.[crossref]

Arico M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, Martinetti M, Rusca MP. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996; 10 (2): 197–203. [PMID]

Jordan MB, Allen CE, Weitzman S. How I treat lymphophagocytic lymphohistiocytosis. Blood. 2011; 118(15): 4041-4052. [crossref]

Fuwa K, Kubota M, Kanno M. Mitochondrial disease as a cause of neonatal hemophagocytic  lymphohistiocytosis. Case Rep Pediatr. 2016; 2016: 3932646 [crossref]

Ramachandran B, Balasubramanian S. Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India. Indian Pediatr. 2011;48(1):31–35. [PMID]

Henter JIAricò MEgeler RM, Elinder G, Favara BE, Filipovich AH, Gadner H, Imashuku S, Janka-Schaub G, Komp D, Ladisch S, Webb D. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol. 1997 May; 28(5): 342-7. [PMID]

Buyse S, Teixeria L, Galicier L. Critical care management of patients with hemaphagocytic lymphohistiocytosis. Intensive Care Med. 2010; 36(10): 1695-1702. [crossref]